In CRC, YY1 was detected to cooperate with HDAC2 to suppress miR‐500a‐5p promoter transcription, while p300 moderates the effect by binding to the upstream YY1‐binding sites of miR‐500a‐5p promoter in CRC cells.58 Here, HDAC2 is linked to colorectal carcinoma.